Ownership Submission

FORM 4

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:

3235-0287

Estimated average burden hours per response...

0.5

(Print or Type Responses)

1. Name and Address of Reporting Person ^*

Bedoya-Toro Munera Maria E

2. Issuer Name and Ticker or Trading Symbol
Dermata Therapeutics, Inc. [DRMA]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

_____ Director	_____ 10% Owner
__X__ Officer (give title below)	_____ Other (specify below)
Senior Vice President

(Last)

(First)

(Middle)

3525 DEL MAR HEIGHTS RD., #332

3. Date of Earliest Transaction (Month/Day/Year)
08/17/2021

(Street)

SAN DIEGO, CA 92130

4. If Amendment, Date Original Filed(Month/Day/Year)

6. Individual or Joint/Group Filing(Check Applicable Line)
_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

(City)

(State)

(Zip)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1.Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	08/17/2021		C		9,162	A	⁽¹⁾	28,674	I	By Munera Family Trust ⁽⁷⁾
Common Stock	08/17/2021		C		19,512	A	⁽²⁾	48,186	I	By Munera Family Trust ⁽⁷⁾
Common Stock	08/17/2021		C		4,878	A	⁽³⁾	53,064	I	By Munera Family Trust ⁽⁷⁾
Common Stock	08/17/2021		C		17,421	A	⁽⁴⁾	70,485	I	By Munera Family Trust ⁽⁷⁾
Common Stock	08/17/2021		C		13,658	A	⁽⁵⁾	84,143	I	By Munera Family Trust ⁽⁷⁾
Common Stock								30,487	D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security
(Instr. 3)

2. Conversion or Exercise Price of Derivative Security

3. Transaction Date (Month/Day/Year)

3A. Deemed Execution Date, if any (Month/Day/Year)

4. Transaction Code
(Instr. 8)

5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)

6. Date Exercisable and Expiration Date
(Month/Day/Year)

7. Title and Amount of Underlying Securities
(Instr. 3 and 4)

8. Price of Derivative Security
(Instr. 5)

9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)

10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)

11. Nature of Indirect Beneficial Ownership
(Instr. 4)

Code

(A)

(D)

Date Exercisable

Expiration Date

Title

Amount or Number of Shares

Series 1d Preferred Stock

⁽¹⁾

08/17/2021

61,821

⁽¹⁾

Common Stock

9,162

$ 0

By Munera Family Trust ⁽⁷⁾

Series 1a Preferred Stock

⁽²⁾

08/17/2021

400,000

⁽²⁾

Common Stock

19,512

$ 0

By Munera Family Trust ⁽⁷⁾

Series 1b Preferred Stock

⁽³⁾

08/17/2021

100,000

⁽³⁾

Common Stock

4,878

$ 0

By Munera Family Trust ⁽⁷⁾

Series 1c Preferred Stock

⁽⁴⁾

08/17/2021

357,142

⁽⁴⁾

Common Stock

17,421

$ 0

By Munera Family Trust ⁽⁷⁾

Series 1 Preferred Stock

⁽⁵⁾

08/17/2021

280,000

⁽⁵⁾

Common Stock

13,658

$ 0

By Munera Family Trust ⁽⁷⁾

Series 1a Warrants

⁽⁶⁾

08/17/2021

100,000

11/15/2016

03/14/2026

Common Stock

4,878

$ 0

By Munera Family Trust ⁽⁷⁾

Warrant to Purchase Common Stock

$ 20.5

08/17/2021

4,878

11/15/2016

03/14/2026

Common Stock

4,878

$ 0

4,878

By Munera Family Trust ⁽⁷⁾

Reporting Owners

Reporting Owner Name / Address	Relationships
Reporting Owner Name / Address	Director	10% Owner	Officer	Other
Bedoya-Toro Munera Maria E 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO, CA 92130			Senior Vice President

Signatures

/s/ Gerald T. Proehl, Attorney-in-Fact		08/17/2021
^**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	The Series 1d Preferred Stock automatically converted into Common Stock of the Issuer upon consummation of the Issuer's initial public offering (the "IPO"). The Series 1d Preferred Stock was convertible at any time and had no expiration date.
(2)	The Series 1a Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1a Preferred Stock was convertible at any time and had no expiration date.
(3)	The Series 1b Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1b Preferred Stock was convertible at any time and had no expiration date.
(4)	The Series 1c Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1c Preferred Stock was convertible at any time and had no expiration date.
(5)	The Series 1 Preferred Stock converted into Common Stock of the Issuer upon consummation of the IPO. The Series 1 Preferred Stock was convertible at any time and had no expiration date.
(6)	The Series 1a Preferred Warrants converted into warrants to purchase Common Stock in connection with the IPO.
(7)	Reporting Person disclaims beneficial ownership of these securities except to the extent of their pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.